As of Sep 27
| +0.10 / +1.77%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +941.67% increase from the last price of 5.76.
The current consensus among 1 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.